Dr. Howard Scher on circulating tumor cells

A new article by Dr. Howard Scher of Memorial Sloan-Kettering Cancer Center on the OncologySTAT web site discusses recent developments in the application of levels of circulating tumor cells (CTCs) in clinical practice and in the assessment of outcomes in clinical trials. … READ MORE …

New, chip-based technology can isolate, identify prostate cancer cells in blood

According to an Associated Press story that came out this morning, Johnson & Johnson and “Boston scientists” are working together on “A blood test so sensitive that it can spot a single cancer cell lurking among a billion healthy ones.” … READ MORE …

Wednesday’s news reports: February 25, 2009 — Part 3

Our third report today covers such topics as:

  • A positive biopsy risk nomogram for men in New Zealand
  • A review of current trends and priorities in surgical technique for radical prostatectomy
  • A review of the potential of functional MRI-based systems for the diagnosis of prostate cancer
  • Demonstration of a relationship between circulating tumor cells and circulating tumor-associated DNA in blood
  • Evaluation of a new, biologically based IMRT treatment planning system … READ MORE …